Iovance Biotherapeutics (IOVA) Misses Q3 EPS by 1c

Iovance Biotherapeutics (NASDAQ: IOVA) reported Q3 EPS of ($0.46), $0.01 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Iovance Biotherapeutics (IOVA) click here.

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• JPMorgan Upgrades Diploma Plc. (DPLM:LN) to Overweight
• Trend Micro Incorporated (4704:JP) (TMICY) PT Lowered to JPY5,900 at Goldman Sachs